Synedgen Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Synedgen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10658
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synedgen Inc (Synedgen) is a biotechnology company that discovers and develops polysaccharide-based drugs, which enhance and mimic the innate immune system. The company’s pipeline products include SYGN305, SYGN399, SYGN303, SYGN313 and SYGN309. Synedgen develops products for the treatment of cystic fibrosis (CF) lung infection; pulmonary infection; COPD; CF obstruction; GI infection, inflammation, mucosal damage and radiation syndrome. It also provides wound care products. The company utilizes glycomics technology platform for cystic fibrosis and other pulmonary conditions to synspira. Synedgen is headquartered in Claremont, California, the US.

Synedgen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synedgen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synedgen Inc, Medical Devices Deals, 2012 to YTD 2018 9
Synedgen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synedgen Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Synedgen Raises USD3 Million in Venture Financing 11
Synedgen Raises USD3 Million in Venture Financing 12
Synedgen Raises USD3.5 Million in Venture Financing 13
Synedgen Raises USD0.6 Million in Venture Financing 14
Synedgen Raises US$3.2 Million In Venture Financing 15
Partnerships 16
Synedgen Enters Into Research Agreement With Cincinnati Children’s Hospital Medical Center And University Of Alabama 16
Licensing Agreements 17
Synspira Enters into Licensing Agreement with Synedgen 17
Synedgen Enters Into Licensing Agreement With Europharma Concepts For Oral Care Products 18
Synedgen Inc – Key Competitors 19
Synedgen Inc – Key Employees 20
Synedgen Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Sep 19, 2018: Synedgen names Kaveri Parker as Chief Business Officer 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Synedgen Inc, Pharmaceuticals & Healthcare, Key Facts 2
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synedgen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synedgen Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Synedgen Inc, Medical Devices Deals, 2012 to YTD 2018 9
Synedgen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synedgen Raises USD3 Million in Venture Financing 11
Synedgen Raises USD3 Million in Venture Financing 12
Synedgen Raises USD3.5 Million in Venture Financing 13
Synedgen Raises USD0.6 Million in Venture Financing 14
Synedgen Raises US$3.2 Million In Venture Financing 15
Synedgen Enters Into Research Agreement With Cincinnati Children’s Hospital Medical Center And University Of Alabama 16
Synspira Enters into Licensing Agreement with Synedgen 17
Synedgen Enters Into Licensing Agreement With Europharma Concepts For Oral Care Products 18
Synedgen Inc, Key Competitors 19
Synedgen Inc, Key Employees 20

List of Figures
Synedgen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synedgen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synedgen Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Synedgen Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dongfang Electric Corporation Ltd (1072):企業の財務・戦略的SWOT分析
    Dongfang Electric Corporation Ltd (1072) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Silver Creek Midstream LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Silver Creek Midstream LLC (Silver Creek) is an independent midstream oil and gas company that acquires, develops and operates crude oil pipeline and storage assets. It offers crude oil gathering, transportation, storage, and terminalling services. The company operates crude oil gathering an …
  • BowLeven plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    BowLeven plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary BowLeven plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operation …
  • Sutter Health-製薬・医療分野:企業M&A・提携分析
    Summary Sutter Health (Sutter Health) is a non-profit healthcare service provider, which provides health care service through its hospitals, ambulatory surgery centers, cardiac centers, cancer centers, rehabilitation centers and others. It serves communities across Northern California- in the San Fr …
  • Flowserve Corporation:企業の戦略・SWOT・財務分析
    Flowserve Corporation - Strategy, SWOT and Corporate Finance Report Summary Flowserve Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Wintershall Holding GmbH:石油・ガス:M&Aディール及び事業提携情報
    Summary Wintershall Holding GmbH (Wintershall) explores for production of oil and natural gas. It operates as a subsidiary of BASF Group. The company holds expertise in conducting geological studies, geophysical measurements, seismic surveys, reservoir modeling, field development, onshore and offsho …
  • Thor Industries, Inc.:企業の戦略・SWOT・財務情報
    Thor Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Thor Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Korea Electric Power Corp:企業の発電所・SWOT分析2018
    Korea Electric Power Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • NorgesGruppen ASA:企業の戦略的SWOT分析
    NorgesGruppen ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • ABB Ltd (ABBN):石油・ガス:M&Aディール及び事業提携情報
    Summary ABB Ltd (ABB) is a provider of industrial technologies. It offers products, systems, solutions, and services in electrification products, motion, industrial automation, industrial automation, and power grids. The company’s offerings harness power reliability, increase industrial productivity …
  • Lycored Ltd:企業の戦略・SWOT・財務情報
    Lycored Ltd - Strategy, SWOT and Corporate Finance Report Summary Lycored Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • APR Energy Ltd:企業の戦略的SWOT分析
    APR Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Les Laboratoires Servier:企業の戦略・SWOT・財務分析
    Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report Summary Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Marafiq:企業の戦略的SWOT分析
    Marafiq - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Velocys Plc (VLS):企業の財務・戦略的SWOT分析
    Velocys Plc (VLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Astellas Pharma Inc (4503):製薬・医療:M&Aディール及び事業提携情報
    Summary Astellas Pharma Inc (Astellas) is a research based pharmaceutical company that discovers, develops, manufactures, and commercializes a wide range of pharmaceuticals. The company’s product portfolio comprises both marketed products for the treatment of a wide range of urological diseases, inf …
  • IHI Corp (7013):企業の財務・戦略的SWOT分析
    IHI Corp (7013) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Toronto Hydro Corporation-エネルギー分野:企業M&A・提携分析
    Summary Toronto Hydro Corporation (Toronto Hydro) is a utility holding company, providing electricity distribution and street lighting services in Toronto through its subsidiaries: Toronto Hydro-Electric System Limited (LDC) and Toronto Hydro Energy Services Inc. (TH Energy). LDC conducts electricit …
  • Thermalin Diabetes LLC-製薬・医療分野:企業M&A・提携分析
    Summary Thermalin Diabetes LLC (Thermalin) is an insulin analogs developer. The company develops concentrated insulin analog for the treatment of individuals with insulin resistance and for use in miniature insulin pumps. It develops both molecular and formulation strategies to produce an acting ana …
  • Prologis, Inc.:企業の戦略・SWOT・財務情報
    Prologis, Inc. - Strategy, SWOT and Corporate Finance Report Summary Prologis, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆